Agoston Agoston, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Esophageal Neoplasms | 18 | 2024 | 1654 | 2.200 |
Why?
|
Barrett Esophagus | 11 | 2024 | 492 | 1.870 |
Why?
|
Adenocarcinoma | 13 | 2023 | 6346 | 1.040 |
Why?
|
Esophagitis, Peptic | 4 | 2024 | 76 | 0.900 |
Why?
|
Esophagectomy | 4 | 2021 | 468 | 0.730 |
Why?
|
Esophagus | 6 | 2018 | 1033 | 0.710 |
Why?
|
Precancerous Conditions | 4 | 2023 | 980 | 0.580 |
Why?
|
Thrombocytosis | 1 | 2017 | 89 | 0.560 |
Why?
|
Mucins | 1 | 2020 | 568 | 0.540 |
Why?
|
Paraneoplastic Syndromes | 1 | 2017 | 155 | 0.510 |
Why?
|
Stomach Neoplasms | 5 | 2019 | 1459 | 0.480 |
Why?
|
Models, Anatomic | 1 | 2018 | 683 | 0.470 |
Why?
|
Neoadjuvant Therapy | 5 | 2024 | 2827 | 0.460 |
Why?
|
Epithelial Cells | 5 | 2018 | 3673 | 0.460 |
Why?
|
Gastritis, Atrophic | 1 | 2013 | 31 | 0.450 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2024 | 736 | 0.380 |
Why?
|
Gastroesophageal Reflux | 5 | 2024 | 819 | 0.360 |
Why?
|
Gastric Mucosa | 1 | 2013 | 604 | 0.360 |
Why?
|
Pilomatrixoma | 1 | 2010 | 24 | 0.350 |
Why?
|
Hair Diseases | 1 | 2010 | 72 | 0.340 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2010 | 247 | 0.340 |
Why?
|
Tumor Suppressor Protein p53 | 6 | 2024 | 2917 | 0.330 |
Why?
|
Stomach | 1 | 2013 | 696 | 0.330 |
Why?
|
Trisomy | 1 | 2010 | 260 | 0.320 |
Why?
|
Wound Healing | 1 | 2018 | 2805 | 0.280 |
Why?
|
DNA Modification Methylases | 1 | 2007 | 210 | 0.270 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 1 | 2007 | 169 | 0.260 |
Why?
|
Carcinoma | 4 | 2023 | 2330 | 0.250 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2019 | 380 | 0.220 |
Why?
|
Retinoblastoma Protein | 1 | 2007 | 672 | 0.220 |
Why?
|
Proton Pump Inhibitors | 3 | 2024 | 532 | 0.210 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2024 | 619 | 0.200 |
Why?
|
Calcium-Binding Proteins | 1 | 2007 | 1069 | 0.200 |
Why?
|
Granuloma, Foreign-Body | 1 | 2021 | 42 | 0.190 |
Why?
|
Carcinoma, Verrucous | 1 | 2021 | 27 | 0.190 |
Why?
|
Esophagogastric Junction | 2 | 2015 | 347 | 0.190 |
Why?
|
Papillomavirus Infections | 2 | 2024 | 1613 | 0.190 |
Why?
|
Gadolinium DTPA | 2 | 2001 | 823 | 0.180 |
Why?
|
Anastomosis, Surgical | 3 | 2019 | 983 | 0.180 |
Why?
|
Exocrine Glands | 1 | 2020 | 46 | 0.180 |
Why?
|
Keratins | 1 | 2021 | 498 | 0.170 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 46 | 0.160 |
Why?
|
Microsatellite Instability | 3 | 2019 | 716 | 0.160 |
Why?
|
Bile Acids and Salts | 2 | 2018 | 393 | 0.160 |
Why?
|
DNA Mismatch Repair | 2 | 2019 | 428 | 0.160 |
Why?
|
Smad4 Protein | 1 | 2019 | 191 | 0.150 |
Why?
|
Colonic Polyps | 1 | 2023 | 554 | 0.150 |
Why?
|
Gallbladder | 1 | 2019 | 308 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2024 | 3639 | 0.150 |
Why?
|
Histoplasmosis | 1 | 2018 | 63 | 0.150 |
Why?
|
Esophagoscopy | 2 | 2018 | 396 | 0.150 |
Why?
|
SOX9 Transcription Factor | 1 | 2018 | 145 | 0.150 |
Why?
|
Proportional Hazards Models | 3 | 2017 | 12463 | 0.140 |
Why?
|
HMGA2 Protein | 1 | 2017 | 102 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9280 | 0.140 |
Why?
|
Ulcer | 1 | 2018 | 204 | 0.140 |
Why?
|
Sigmoid Diseases | 1 | 2017 | 59 | 0.140 |
Why?
|
Gastrectomy | 1 | 2021 | 672 | 0.140 |
Why?
|
Colon, Sigmoid | 1 | 2017 | 124 | 0.140 |
Why?
|
Magnetics | 1 | 2019 | 599 | 0.140 |
Why?
|
Metaplasia | 2 | 2014 | 322 | 0.130 |
Why?
|
Ki-67 Antigen | 1 | 2018 | 629 | 0.130 |
Why?
|
Repressor Proteins | 1 | 2007 | 2986 | 0.130 |
Why?
|
Triazenes | 1 | 2015 | 8 | 0.130 |
Why?
|
Mucous Membrane | 2 | 2016 | 659 | 0.130 |
Why?
|
Cell Cycle Proteins | 1 | 2007 | 3448 | 0.130 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2015 | 68 | 0.120 |
Why?
|
Colonic Neoplasms | 2 | 2017 | 2538 | 0.120 |
Why?
|
Platelet Count | 1 | 2017 | 781 | 0.120 |
Why?
|
Disease Progression | 4 | 2023 | 13506 | 0.110 |
Why?
|
Biopsy | 5 | 2018 | 6766 | 0.110 |
Why?
|
Breast Neoplasms | 6 | 2017 | 21012 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2018 | 2825 | 0.110 |
Why?
|
Epithelium | 1 | 2018 | 1603 | 0.110 |
Why?
|
Jejunum | 1 | 2015 | 472 | 0.110 |
Why?
|
SOXB1 Transcription Factors | 1 | 2015 | 286 | 0.110 |
Why?
|
Aged | 18 | 2024 | 169289 | 0.110 |
Why?
|
Middle Aged | 21 | 2024 | 220895 | 0.100 |
Why?
|
Remission Induction | 2 | 2015 | 2396 | 0.100 |
Why?
|
Liver Regeneration | 1 | 2014 | 213 | 0.100 |
Why?
|
Iodide Peroxidase | 1 | 2014 | 294 | 0.100 |
Why?
|
Nuclear Proteins | 2 | 2017 | 5796 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2024 | 3492 | 0.100 |
Why?
|
Contrast Media | 3 | 2011 | 5311 | 0.100 |
Why?
|
Catheter Ablation | 2 | 2016 | 2751 | 0.100 |
Why?
|
Humans | 43 | 2024 | 761504 | 0.100 |
Why?
|
Time Factors | 8 | 2021 | 39967 | 0.100 |
Why?
|
Female | 28 | 2024 | 392644 | 0.100 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2011 | 33 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2021 | 3514 | 0.090 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4111 | 0.090 |
Why?
|
Aged, 80 and over | 11 | 2021 | 58976 | 0.090 |
Why?
|
STAT3 Transcription Factor | 1 | 2015 | 871 | 0.090 |
Why?
|
Male | 25 | 2024 | 360804 | 0.090 |
Why?
|
Skin Neoplasms | 1 | 2010 | 5821 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1136 | 0.090 |
Why?
|
Hyperplasia | 1 | 2013 | 1152 | 0.090 |
Why?
|
Chromosome Banding | 1 | 2010 | 260 | 0.090 |
Why?
|
Carcinoma in Situ | 1 | 2016 | 791 | 0.090 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1363 | 0.090 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2915 | 0.080 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2015 | 874 | 0.080 |
Why?
|
Liver | 2 | 2015 | 7529 | 0.080 |
Why?
|
Mucin-1 | 1 | 2013 | 540 | 0.080 |
Why?
|
Immunohistochemistry | 5 | 2017 | 11076 | 0.080 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2416 | 0.080 |
Why?
|
Cell Differentiation | 3 | 2018 | 11528 | 0.080 |
Why?
|
Trans-Activators | 1 | 2018 | 2856 | 0.080 |
Why?
|
Colitis | 1 | 2017 | 1233 | 0.080 |
Why?
|
Neuroendocrine Tumors | 1 | 2014 | 641 | 0.080 |
Why?
|
Antirheumatic Agents | 1 | 2018 | 1372 | 0.080 |
Why?
|
Cell Line, Tumor | 4 | 2016 | 16981 | 0.070 |
Why?
|
Epigenesis, Genetic | 2 | 2014 | 3802 | 0.070 |
Why?
|
Colon | 1 | 2015 | 1792 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2018 | 10445 | 0.070 |
Why?
|
Hepatocytes | 1 | 2014 | 1233 | 0.070 |
Why?
|
Treatment Outcome | 7 | 2024 | 64680 | 0.070 |
Why?
|
Transcription Factors | 2 | 2017 | 12128 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8181 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4026 | 0.070 |
Why?
|
Genomics | 2 | 2023 | 5821 | 0.070 |
Why?
|
Nitric Oxide | 1 | 2015 | 2135 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2014 | 1897 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2017 | 3466 | 0.060 |
Why?
|
Risk Factors | 6 | 2023 | 74206 | 0.060 |
Why?
|
Cohort Studies | 3 | 2017 | 41487 | 0.060 |
Why?
|
Stem Cells | 1 | 2018 | 3522 | 0.060 |
Why?
|
Adult | 12 | 2021 | 221177 | 0.060 |
Why?
|
Cell Line | 4 | 2018 | 15601 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6814 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3201 | 0.060 |
Why?
|
Th1 Cells | 1 | 2009 | 1036 | 0.060 |
Why?
|
Th2 Cells | 1 | 2009 | 1060 | 0.060 |
Why?
|
Cell Movement | 3 | 2024 | 5203 | 0.060 |
Why?
|
Immunoblotting | 1 | 2007 | 1646 | 0.060 |
Why?
|
RNA, Messenger | 4 | 2022 | 12795 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2021 | 80636 | 0.060 |
Why?
|
Histone Deacetylases | 1 | 2008 | 719 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2023 | 6935 | 0.050 |
Why?
|
Ubiquitin | 1 | 2008 | 839 | 0.050 |
Why?
|
RNA Stability | 1 | 2005 | 329 | 0.050 |
Why?
|
Chromosomal Instability | 1 | 2023 | 178 | 0.050 |
Why?
|
Prognosis | 3 | 2018 | 29625 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 1 | 2018 | 3763 | 0.050 |
Why?
|
Boston | 1 | 2015 | 9326 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4511 | 0.050 |
Why?
|
Human papillomavirus 16 | 1 | 2024 | 267 | 0.050 |
Why?
|
Mitochondria | 1 | 2015 | 3624 | 0.050 |
Why?
|
Animals | 11 | 2019 | 168459 | 0.050 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2008 | 1320 | 0.050 |
Why?
|
Signal Transduction | 4 | 2018 | 23445 | 0.050 |
Why?
|
North America | 1 | 2024 | 1276 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 4 | 2011 | 36426 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2009 | 2547 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4575 | 0.040 |
Why?
|
Transfection | 1 | 2007 | 5774 | 0.040 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12974 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11903 | 0.040 |
Why?
|
Muscle Neoplasms | 1 | 1999 | 130 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9177 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4876 | 0.040 |
Why?
|
Histoplasma | 1 | 2018 | 39 | 0.040 |
Why?
|
Neoplasms | 1 | 2007 | 22170 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 17635 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2007 | 3429 | 0.040 |
Why?
|
Carcinoma, Lobular | 1 | 2002 | 481 | 0.040 |
Why?
|
Swine | 2 | 2019 | 5915 | 0.040 |
Why?
|
DNA, Viral | 1 | 2024 | 2202 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2014 | 8547 | 0.030 |
Why?
|
DNA Methylation | 2 | 2009 | 4398 | 0.030 |
Why?
|
2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2016 | 32 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 1999 | 647 | 0.030 |
Why?
|
Neoplasm Staging | 3 | 2017 | 11121 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2016 | 404 | 0.030 |
Why?
|
Omeprazole | 1 | 2016 | 105 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2018 | 546 | 0.030 |
Why?
|
Up-Regulation | 2 | 2018 | 4124 | 0.030 |
Why?
|
Adenoma, Islet Cell | 1 | 2014 | 72 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2023 | 3595 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 370 | 0.030 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2002 | 1085 | 0.030 |
Why?
|
Mutation | 4 | 2024 | 30052 | 0.030 |
Why?
|
Carbon Tetrachloride | 1 | 2014 | 72 | 0.030 |
Why?
|
Toxins, Biological | 1 | 2014 | 60 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2016 | 784 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2015 | 867 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 523 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2005 | 13446 | 0.030 |
Why?
|
Culture Media | 1 | 2015 | 897 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 718 | 0.030 |
Why?
|
Young Adult | 2 | 2019 | 59243 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13639 | 0.030 |
Why?
|
Pressure | 1 | 2015 | 1154 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2016 | 633 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 698 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1900 | 0.020 |
Why?
|
Methylation | 1 | 2014 | 1084 | 0.020 |
Why?
|
Withholding Treatment | 1 | 2016 | 617 | 0.020 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 954 | 0.020 |
Why?
|
beta Catenin | 1 | 2016 | 1040 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2017 | 2510 | 0.020 |
Why?
|
Cadherins | 1 | 2016 | 903 | 0.020 |
Why?
|
Eosinophils | 1 | 2016 | 950 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2015 | 637 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2015 | 899 | 0.020 |
Why?
|
Gene Amplification | 1 | 2015 | 1089 | 0.020 |
Why?
|
Rats | 2 | 2018 | 23742 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1612 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 2016 | 1078 | 0.020 |
Why?
|
Mice | 5 | 2016 | 81525 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2024 | 7594 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2358 | 0.020 |
Why?
|
Point Mutation | 1 | 2015 | 1595 | 0.020 |
Why?
|
Necrosis | 1 | 2014 | 1611 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2017 | 9606 | 0.020 |
Why?
|
Gastritis | 1 | 2011 | 199 | 0.020 |
Why?
|
Organ Specificity | 1 | 2014 | 1967 | 0.020 |
Why?
|
Cisplatin | 1 | 2015 | 1651 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9420 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3606 | 0.020 |
Why?
|
MicroRNAs | 1 | 2024 | 3816 | 0.020 |
Why?
|
Lymphocytes | 1 | 2016 | 2612 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2011 | 635 | 0.020 |
Why?
|
Helicobacter Infections | 1 | 2011 | 388 | 0.020 |
Why?
|
Paclitaxel | 1 | 2015 | 1732 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18252 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2001 | 4063 | 0.020 |
Why?
|
Risk Assessment | 2 | 2021 | 23995 | 0.020 |
Why?
|
Child, Preschool | 1 | 2010 | 42230 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2014 | 14414 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6484 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2865 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12441 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 17904 | 0.020 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2008 | 424 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 2008 | 481 | 0.020 |
Why?
|
China | 1 | 2011 | 2369 | 0.020 |
Why?
|
Chromatin | 1 | 2016 | 2960 | 0.020 |
Why?
|
Body Weight | 1 | 2015 | 4618 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2007 | 11118 | 0.010 |
Why?
|
Histones | 1 | 2014 | 2580 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2015 | 5247 | 0.010 |
Why?
|
Recovery of Function | 1 | 2014 | 2979 | 0.010 |
Why?
|
Neutrophils | 1 | 2016 | 3767 | 0.010 |
Why?
|
Patient Selection | 1 | 2015 | 4244 | 0.010 |
Why?
|
Genetic Markers | 1 | 2009 | 2601 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2011 | 2010 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4174 | 0.010 |
Why?
|
Mastectomy, Modified Radical | 1 | 2002 | 62 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2011 | 2651 | 0.010 |
Why?
|
Child | 1 | 2010 | 80153 | 0.010 |
Why?
|
Adolescent | 1 | 2010 | 88319 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2009 | 3162 | 0.010 |
Why?
|
Gene Silencing | 1 | 2007 | 1509 | 0.010 |
Why?
|
Gene Deletion | 1 | 2008 | 2665 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22176 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2008 | 1974 | 0.010 |
Why?
|
Indoles | 1 | 2008 | 1833 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7967 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2008 | 2909 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18395 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15266 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2009 | 5486 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 3712 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16591 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12725 | 0.010 |
Why?
|
Mastectomy, Segmental | 1 | 2002 | 955 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9539 | 0.010 |
Why?
|
Capillary Permeability | 1 | 1999 | 773 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12690 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1999 | 2016 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 6485 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 54425 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 18965 | 0.010 |
Why?
|
Rabbits | 1 | 1999 | 4772 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39106 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 15631 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 22169 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20570 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2002 | 20098 | 0.000 |
Why?
|
United States | 1 | 2011 | 72334 | 0.000 |
Why?
|